E375G reduces the activation ability of CaMKK1 on the downstream kinase and weakens the effect of its downstream pathway in terms of promoting the growth of lung cancer cells and inhibiting their apoptosis, which ultimately leads to a better prognosis. Here, CAMKK1 is linked to lung carcinoma.